Variant report
Variant | esv2762332 |
---|---|
Chromosome Location | chr3:68881162-68890638 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549932993 | chr3:68881174-68881175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569731151 | chr3:68881176-68881177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563658888 | chr3:68881177-68881178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564141405 | chr3:68881209-68881210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs60916515 | chr3:68881210-68881211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74902451 | chr3:68881225-68881226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535462707 | chr3:68881232-68881233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376296876 | chr3:68881239-68881240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548950053 | chr3:68881246-68881247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565974150 | chr3:68881262-68881263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534650096 | chr3:68881283-68881284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529372493 | chr3:68881334-68881335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577789278 | chr3:68881393-68881394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183905142 | chr3:68881397-68881398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556254706 | chr3:68881448-68881449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs377643292 | chr3:68881463-68881464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541826310 | chr3:68881464-68881465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149685190 | chr3:68881481-68881482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141490206 | chr3:68881502-68881503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149610316 | chr3:68881503-68881504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566017478 | chr3:68881511-68881512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528770355 | chr3:68881531-68881532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147775255 | chr3:68881548-68881549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541411372 | chr3:68881572-68881573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564781774 | chr3:68881606-68881607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533579016 | chr3:68881613-68881614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550366805 | chr3:68881622-68881623 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563374269 | chr3:68881637-68881638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528953611 | chr3:68881653-68881654 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549089009 | chr3:68881661-68881662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565585458 | chr3:68881667-68881668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534588938 | chr3:68881688-68881689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551420959 | chr3:68881721-68881722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571484708 | chr3:68881754-68881755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536869162 | chr3:68881783-68881784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374656682 | chr3:68881793-68881794 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs367950143 | chr3:68881839-68881840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535595534 | chr3:68881858-68881859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200509054 | chr3:68881861-68881862 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555828985 | chr3:68881882-68881883 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4855345 | chr3:68881937-68881938 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs113061922 | chr3:68881945-68881946 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564644439 | chr3:68881997-68881998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188730839 | chr3:68882009-68882010 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537277931 | chr3:68882012-68882013 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576615909 | chr3:68882041-68882042 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180808716 | chr3:68882043-68882044 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563912758 | chr3:68882068-68882069 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147640858 | chr3:68882131-68882132 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185764918 | chr3:68882170-68882171 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68875400-68882000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr3:68881600-68882200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr3:68882000-68882200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr3:68882000-68882200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr3:68882000-68882200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr3:68882000-68882200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr3:68882000-68882200 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr3:68882000-68882400 | Enhancers | Gastric | stomach |
9 | chr3:68887800-68888000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr3:68889000-68889400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |